SavedAdd your journal

Journals / Anadolu Psikiyatri Dergisi / 2013 / Cilt: 14 - Sayı: 1

Peripheral edema associated with mirtazapine: a case report

Mirtazapine bağlı periferik ödem: Olgu sunumu

Birmay ÇAM
Hüseyin KURT
Pages
84–86
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In medical literature this is the fourth report of peripheral edema associated with the mirtazapine.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mirtazapine increasing both noradrenergic and serotonergic efficiency and also having effect of decreasing anxiety is a tetracyclic antidepressant.
📊
Key Findings & Data:Mirtazapine are rarely associated with peripheral edema.
💡
Conclusion & Impact:In medical literature this is the fourth report of peripheral edema associated with the mirtazapine.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Mirtazapine increasing both noradrenergic and serotonergic efficiency and also having effect of decreasing anxiety is a tetracyclic antidepressant. Mirtazapine are rarely associated with peripheral edema. The mechanism of peripheral edema caused by the use of mirtazapine is unknown. In this article, we aimed to discuss a case of edema occurred during treatment of mirtazapine. In medical literature this is the fourth report of peripheral edema associated with the mirtazapine.

Özet

Mirtazapin hem noradrenerjik, hem de serotonerjik etkinliği artıran, bunaltı giderici etkisi de olan bir tetrasiklik anti- depresandır. Mirtazapin nadiren periferik ödeme neden olur. Mirtazapin kullanımına bağlı periferik ödemin meka- nizması bilinmemektedir. Bu yazıda, mirtazapine bağlı ödem gelişen bir olgu tartışılmıştır. Bu olgu, tıbbi literatürde mirtazapin kullanımına bağlı ödem gelişen dördüncü olgudur. (Anadolu Psikiyatri Derg 2013; 14:84-86)

🔖

Cite This Article

ÇAM, B., KURT, H. (2013). Peripheral edema associated with mirtazapine: a case report. Anadolu Psikiyatri Dergisi, Cilt: 14 - Sayı: 1, 84–86. https://ajindex.com/articles/356394

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Stahl SM. Essential Psychopharmacology. The Prescriber’s Guide. Cambridge, Cambridge Uni- versity Press, 2005
  2. Remick RA, Froeze C, Keller FD. Common side effects associated with monoamine oxidase inhi- bitors. Prog Neuropsychopharmacol Biol Psychi- atry 1989; 13:497-504
  3. Masdrakis VG, Oulis P, Kouzoupis AV, Masdra- kis GV, Soldatos CR. Bilateral ankle oedema in a patient taking escitalopram. World J Biol Psychi- atry 2009; 10:939-941
  4. Dadić-Hero E, Ružić K, Grahovac T, Graovac M, Palijan TZ, Sepić-Grahovac D. Allergic reactions outcome of sertraline and escitalopram treat- ments. Psychiatr Danub 2011; 23:120-122
  5. Food and Drug Administration. Remeron (mirta- zapine) summary basis of approval. Washington, DC, Food and Drug Administration, 1996. Anatolian Journal of Psychiatry 2013; 14:84-86 6. Biswas PN, Wilton LV, Shakir SA. The pharma- covigilance of mirtazapine: results of a prescrip- tion event monitoring study on 13554 patients in England. J Psychopharmacol 2003; 17:121-126
  6. Sarısoy G, Yazıcı N. Olanzapin ve mirtazapinin birlikte kullanımıyla ilişkili periferik ödem: Olgu sunumu. Klinik Psikofarmakoloji Bülteni 2011; 21:249-252
  7. Lahdelma L, Bruin R. The clinical course and resolution of mirtazapine induced edema. Eur Psychiatry 1998; 13(Suppl.4):265-266
  8. Kutscher EC, Lund BC, Hartman BA. Peripheral edema associated with mirtazapine. Ann Phar macother 2001; 35:1494-1495
  9. Deshauer D, Erwin L, Karagianis J. Case report: edema related to olanzapine theraphy. Can Fam Physician 2006; 52:620-621.